ALS News & Research For postings of news or research links and articles related to ALS


advertisement
Reply
 
Thread Tools Display Modes
Old 12-11-2008, 04:53 PM #1
BobbyB's Avatar
BobbyB BobbyB is offline
In Remembrance
 
Join Date: Aug 2006
Location: North Carolina
Posts: 4,609
15 yr Member
BobbyB BobbyB is offline
In Remembrance
BobbyB's Avatar
 
Join Date: Aug 2006
Location: North Carolina
Posts: 4,609
15 yr Member
Thumbs up Researchers replicate ALS process in lab dish


Researchers led by Kevin Eggan have taken another step forward in battling Lou Gehrig’s disease.
Matt Craig/Harvard News Office


Researchers replicate ALS process in lab dish
By B.D. Colen

Harvard News Office

A Harvard Stem Cell Institute (HSCI) research team has succeeded in deriving spinal motor neurons from human embryonic stem cells, and has then used them to replicate the Amyotrophic Lateral Sclerosis (ALS) disease process in a laboratory dish.

The researchers, led by HSCI principal faculty member Kevin Eggan, found that human motor neurons exposed to glial cells carrying a known genetic mutation associated with ALS died, while other types of neurons exposed to the disease-carrying glial cells were unaffected.

“The logical next step is to ask what the glial cells are doing to kill the motor neurons,” said Eggan, an assistant professor in Harvard’s new inter-School Department of Stem Cell and Regenerative Biology.

Eggan said that the new findings are particularly important for ALS research because they answer the field’s long-standing “murder or suicide” question. That is, do motor neurons in patients with ALS — an always-fatal, neurodegenerative condition commonly known as Lou Gehrig’s disease — die because of something inherent to the motor neurons, do they “commit suicide?” Or, are they “murdered” — is there something external killing them? This latest research strongly suggests that the motor neurons are being “murdered” by something in the glial cells carrying a mutation of the SOD1 gene.

Additionally, Eggan said, this latest study is “important for stem cell science because one of the things we’ve been promising is that these stem cells would be important for drug discovery. We’ve produced industrial quantities of these motor neurons; we’ve shown that this does work, that you can overcome the technical limitations. This is a disease process in a petri dish, and that’s what we’ve been promising.”

Finally, he said, this experiment once again proves the utility of human embryonic stem cells, and confirms the value of continuing to use them to study both normal development and disease process, particularly as there have yet to be studies demonstrating that alternative types of cells are identical in all respects to human embryonic stem cells.

In addition to replicating the disease process, Eggan, postdoctoral fellow Paolo DiGiorgio and colleagues Gabriella L. Boulting and Samuel Bobrowicz demonstrated that an inflammatory pathway plays a role in the disease process, and they found a small molecule that has at least some protective effect. Eggan noted, however, that when that same compound has been tested on ALS patients it has not slowed the disease process. “We don’t know,” he said, “whether there may be other issues there, whether there are problems involving the blood-brain barrier, or dosing levels.”

Less than six months ago, using induced pluripotent stem cell (iPS) technology, a team lead by Eggan, who in addition to his Harvard titles is a Stowers Medical Institute Investigator, produced patient-specific stem cell lines from the skin cells of ALS patients.

In spring 2007, Eggan and colleagues created an ALS model using mouse stem cells. But research findings in animal models always beg the question of whether the results will translate directly to humans. In this case, the answer to that question is a resounding “Yes!”

The publication of this latest paper in the journal Cell Stem Cell is only the second report in the literature of human stem cell work resulting in the replication of a disease process in a laboratory dish. That work, involving Fragile X Syndrome, did not involve the derivation of a specific cell type.

bd_colen@harvard.edu

http://www.news.harvard.edu/gazette/...1-alsstem.html
__________________

.

ALS/MND Registry

.
BobbyB is offline   Reply With QuoteReply With Quote

advertisement
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
Pick your favorite dish ewizabeth The Stumble Inn 31 12-03-2008 09:33 PM
Holiday Specialty Dish? Kitty The Stumble Inn 15 11-15-2008 05:31 PM
Ideas for a large, simple side dish? FaithS Social Chat 43 01-29-2008 08:03 AM
U of I professor finds ways to replicate brain patterns BobbyB ALS News & Research 0 08-30-2007 12:30 PM


All times are GMT -5. The time now is 06:12 PM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.